oclacitinib maleate (Apoquel)
Jump to navigation
Jump to search
Indications
- pruritus associated with allergic dermatitis in dogs
- atopic dermatitis in dogs
Mechanism of action
- Janus kinase inhibitor
- preferentially inhibits JAK1 over other family members
More general terms
References
- ↑ Collard WT et al The pharmacokinetics of oclacitinib maleate, a Janus kinase inhibitor, in the dog. Journal of Veterinary Pharmacology and Therapeutics. 16 DEC 2013 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/24330031 <Internet> http://onlinelibrary.wiley.com/doi/10.1111/jvp.12087/abstract
- ↑ European Medicines Agency Apoquel http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/veterinary/medicines/002688/vet_med_000280.jsp&mid=WC0b01ac058008d7a8